MPM BioImpact LLC - INHIBRX INC ownership

INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 108 filers reported holding INHIBRX INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of INHIBRX INC
ValueSharesWeighting
Q1 2023$22,498,342
-29.0%
1,192,281
-7.3%
5.84%
-28.9%
Q4 2022$31,697,758
+38.0%
1,286,435
+0.5%
8.22%
+51.1%
Q3 2022$22,976,000
+97.8%
1,279,995
+25.1%
5.44%
+68.7%
Q2 2022$11,615,0001,023,3253.23%
Other shareholders
INHIBRX INC shareholders Q2 2023
NameSharesValueWeighting ↓
TCG Crossover Management, LLC 1,750,387$32,119,6014.73%
Perceptive Advisors 4,256,104$78,099,5082.60%
RA Capital Management 4,724,207$86,689,1981.71%
Birchview Capital, LP 70,448$1,292,7211.10%
Soleus Capital Management, L.P. 549,183$10,077,5080.93%
Sofinnova Investments, Inc. 743,294$13,639,4450.86%
SPHERA FUNDS MANAGEMENT LTD. 256,371$4,704,4080.86%
Meridian Wealth Advisors, LLC 122,315$2,244,4810.56%
VIKING GLOBAL INVESTORS LP 7,150,826$131,217,6570.53%
Velan Capital Investment Management LP 25,000$458,7500.37%
View complete list of INHIBRX INC shareholders